LEADER 01307nam 2200409 450 001 9910583376503321 010 $a0-08-102758-3 035 $a(CKB)4100000005248970 035 $a(MiAaPQ)EBC5455402 035 $a(PPN)233365893 035 $a(EXLCZ)994100000005248970 100 $a20180816d2018 uy 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aHealth data processing $esystemic approaches /$fFieschi, Marius ; with the contribution of Jean-Charles Dufour 210 1$aLondon, UK :$cISTE Press Ltd ;$aOxford, UK :$cElsevier Ltd,$d2018. 215 $a1 online resource (342 pages) 225 1 $aHealth industrialization set 311 $a1-78548-287-4 410 0$aHealth industrialization set. 606 $aHealth services administration$xData processing 606 $aMedical informatics 615 0$aHealth services administration$xData processing. 615 0$aMedical informatics. 676 $a362.1068 700 $aFieschi$b M$g(Marius),$0907607 702 $aDufour$b Jean-Charles 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910583376503321 996 $aHealth data processing$92030316 997 $aUNINA LEADER 01087nam a2200277 i 4500 001 991003061699707536 005 20020509111502.0 008 940228s1976 it ||| | grc 035 $ab11102925-39ule_inst 035 $aPARLA174358$9ExL 040 $aDip.to Filol. Class. e Med. - Sala$bita 082 0 $a481 100 1 $aCrawford, David S.$087134 245 10$aFuad 1. university papyri /$cedited by David S. Crawford 260 $aMilano :$bCisalpino - La Goliardica,$c1976 300 $aXI, 138 p. ;$c25 cm. 490 0 $aPublications de la Société Fouad I de Papyrologie. Textes et documents ;$v8 500 $aFacs. dell'ed.: Alexandrie : Sociétè de Publications Egyptiennes, 1949. 650 4$aPapiri documentari - Greci 740 0 $aP Fuad Crawford 907 $a.b11102925$b23-02-17$c28-06-02 912 $a991003061699707536 945 $aLE007 P A 1690$g1$i2007000019559$lle007$o-$pE0.00$q-$rn$so $t0$u0$v0$w0$x0$y.i11237351$z28-06-02 996 $aFuad 1. university papyri$9857532 997 $aUNISALENTO 998 $ale007$b01-01-94$cm$da $e-$fgrc$git $h0$i1 LEADER 05503nam 2200697 450 001 9910816401303321 005 20230807203854.0 010 $a3-527-67584-1 010 $a3-527-67582-5 010 $a3-527-67585-X 035 $a(CKB)2550000001349269 035 $a(EBL)1776987 035 $a(SSID)ssj0001400161 035 $a(PQKBManifestationID)11926782 035 $a(PQKBTitleCode)TC0001400161 035 $a(PQKBWorkID)11477605 035 $a(PQKB)10036213 035 $a(MiAaPQ)EBC1776987 035 $a(Au-PeEL)EBL1776987 035 $a(CaPaEBR)ebr10935049 035 $a(CaONFJC)MIL640760 035 $a(OCoLC)890090228 035 $a(EXLCZ)992550000001349269 100 $a20141001h20152015 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aBio- and bioinspired nanomaterials /$fedited by Daniel Ruiz-Molina, Fernando Novio, and Claudio Roscini 210 1$aWeinheim, Germany :$cWiley-VCH,$d2015. 210 4$d©2015 215 $a1 online resource (487 p.) 300 $aDescription based upon print version of record. 311 $a1-322-09509-4 311 $a3-527-33581-1 320 $aIncludes bibliographical references at the end of each chapters and index. 327 $aBio- and Bioinspired Nanomaterials; Contents; List of Contributors; Foreword; Preface; Part I: Bionanomaterials; 1 Synthesis of Colloidal Gold and Silver Nanoparticles and their Properties; 1.1 Introduction; 1.2 Physical and Chemical Properties of Gold and Silver Nanoparticles; 1.2.1 Optical Properties of Gold and Silver Nanoparticles; 1.2.2 Electronic Properties of Gold and Silver Nanoparticles; 1.3 Synthesis of Gold and Silver Core Nanoparticles; 1.4 Transfer to Aqueous Media of Gold and Silver Nanoparticles from Organic Solvents; 1.5 Some Applications of Gold and Silver Nanoparticles 327 $aAcknowledgmentsReferences; 2 Ceramic Smart Drug Delivery Nanomaterials; 2.1 Introduction; 2.2 Biodistribution, Toxicity, and Excretion of Nanoparticles; 2.3 Mesoporous Silica Nanoparticles; 2.4 Calcium Phosphate Nanoparticles; 2.5 Carbon Allotropes; 2.6 Iron Oxide Nanoparticles; References; 3 Polymersomes and their Biological Implications; 3.1 Introduction; 3.2 Self-Assembly of Amphiphiles; 3.3 Polymersome - The Synthetic Analog of a Liposome; 3.3.1 Polymersome Preparation Methods; 3.3.1.1 Batch Methods; 3.3.1.2 Continuous Flow Methods; 3.3.2 Characterization of Polymersomes 327 $a3.4 Polymersomes as Drug Delivery Devices3.4.1 Tuning Membrane Properties and Controlling the Release; 3.4.1.1 pH-Responsive Polymersomes; 3.4.1.2 Hydrolysis of Polymersomes Built from Biodegradable Polymers; 3.4.1.3 GSH-Responsive (Redox) Vesicles; 3.4.1.4 Temperature-Responsive Polymers; 3.4.1.5 Magnetic Release; 3.4.2 Surface Functionalization and Targeting Strategies; 3.5 Embedding Channel Proteins in Artificial Polymer Membranes and Creating New Applications; 3.6 Conclusions and Outlook; List of Abbreviations; References; 4 MOFs in Pharmaceutical Technology; 4.1 Introduction 327 $a4.2 Metal-Organic Frameworks4.2.1 Description; 4.2.2 Synthesis, Formulation, and Functionalization/Shaping; 4.2.2.1 Synthesis and Formulation/Shaping; 4.2.2.2 Functionalization; 4.2.3 Stability and Toxicity; 4.3 MOFs for Therapeutics; 4.3.1 BioMOFs; 4.3.2 Active Ingredient Adsorption and Release from MOFs; 4.3.2.1 Drugs; 4.3.2.2 Cosmetics; 4.3.3 Understanding; 4.3.3.1 Encapsulation; 4.3.3.2 Release; 4.3.4 Theranostics; 4.3.5 Efficacy; 4.4 Conclusions; List of Abbreviations; References; 5 Amorphous Coordination Polymer Particles for Biomedicine; 5.1 Introduction 327 $a5.2 Interaction of Nanoplatforms with the Biological Environment5.3 CPPs as Realistic Alternative to Classical Nanosystems; 5.3.1 Encapsulation Systems Based on CPPs; 5.3.2 Active Metal-Organic Units; 5.3.2.1 Active Metal Ions; 5.3.2.2 Drugs as Bridging Ligands; 5.3.2.3 Active Complexes; 5.3.3 Smart Delivery Systems; 5.3.4 Bioimaging; 5.3.5 Biocompatibility of CPPs; 5.4 Conclusion and Future Challenges; References; 6 Magnetic Nanoparticles for Magnetic Hyperthermia and Controlled Drug Delivery; 6.1 Introduction; 6.2 Principles of Magnetically Induced Heat Generation 327 $a6.3 Synthesis of MNPs and their Heat Performance 330 $aA comprehensive overview of nanomaterials that are inspired by or targeted at biology, including some of the latest breakthrough research. Throughout, valuable contributions from top-level scientists illustrate how bionanomaterials could lead to novel devices or structures with unique properties. The first and second part cover the most relevant synthetic and bioinspired nanomaterials, including surfaces with extreme wettability properties, functional materials with improved adhesion or structural and functional systems based on the complex and hierarchical organization of natural composites. 606 $aBioinorganic chemistry 606 $aInorganic compounds 606 $aNanostructured materials 615 0$aBioinorganic chemistry. 615 0$aInorganic compounds. 615 0$aNanostructured materials. 676 $a572.51 702 $aRuiz-Molina$b Daniel 702 $aNovio$b Fernando 702 $aRoscini$b Claudio 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910816401303321 996 $aBio- and bioinspired nanomaterials$93983228 997 $aUNINA